Journal profile · Multiple
Reproductive Medicine and Biology
ISSN 1445-5781 · eISSN 1447-0578 · WILEY · JAPAN
Reproductive Medicine and Biology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.26; fully open access; APC about USD 1,850; median 91 days to acceptance (99 articles, last 24 months); acceptance rate 21% (journal website); 93 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Reproductive Medicine and Biology is published by WILEY and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Reproductive Biology and Fertility, Ovarian function and disorders and Sperm and Testicular Function, together about 48.6% of its articles. Its main subfields are Reproductive Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Reproductive Medicine and Biology (RMB) is the official English language open access journal of the Japan Society for Reproductive Medicine, the Japan Society of Fertilization and Implantation, the Japan Society of Andrology, and the Japan Society for Ova Research, and welcomes submissions from the members and the non-members. RMB publishes original research articles that report new findings or concepts in all aspects of reproductive phenomena in all kinds of mammals. Manuscripts in the following fields will be considered: andrology, endocrinology, oncology, immunology, genetics, function of gonads and genital tracts, erectile dysfunction, gametogenesis, function of accessory sex organs, fertilization, embryogenesis, embryo culture, embryo manipulation, early pregnancy, implantation, ontogenesis, infectious disease, contraception, infertility treatment, surgery, and ethics and social issues, at the biological, biochemical, biophysical, molecular biological, analytically morphological, and clinical levels. Reports on techniques applicable to the above fields are also considered. Original Articles, Research Notes, and Case Reports will be accepted, but not preliminary reports. Review and Mini review articles are usually submitted upon invitation by the Editors, but the Editorial Board welcomes voluntary contributions. A review should be a focused, brief treatment of a contemporary development in a single area. Editorial articles are usually submitted upon invitation by the Editors. Commentary, Opinion, Perspective are also considered for review. Abstracting and Indexing Information Academic OneFile (GALE Cengage) Biological Abstracts (Clarivate Analytics) BIOSIS Previews (Clarivate Analytics) CAS: Chemical Abstracts Service (ACS) Current Contents: Clinical Medicine (Clarivate Analytics) Embase (Elsevier) Open Access Journal Index – OAJ (NSLC & CEPIEC) PubMed (NLM) Science Citation Index Expanded (Clarivate Analytics) SCOPUS (Elsevier) Web of Science (Clarivate Analytics) Reproductive Medicine and Biology deposits all articles in PMC (PubMed Central)
From the journal's Aims & Scope
Research area (LetPub): Multiple
Editor-in-chief Masayuki SHIMADAPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named Japan 59, South Korea 3, Taiwan, China 2, United States 2, Mainland China 1 (74 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Reproductive Biology and FertilityMedicine21.7%
- Ovarian function and disordersMedicine14.7%
- Sperm and Testicular FunctionMedicine12.2%
- Reproductive System and PregnancyImmunology and Microbiology8.1%
- Reproductive Health and TechnologiesMedicine6.3%
- Assisted Reproductive Technology and Twin PregnancyMedicine4.4%
- Endometriosis Research and TreatmentMedicine4.3%
- Gynecological conditions and treatmentsMedicine3.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Obstetrics & Gynecology | Zone 3 |
| Minor | Reproductive Biology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Obstetrics & Gynecology | Zone 3 |
| Minor | Reproductive Biology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Reproductive Biology | Zone 3 |
| Minor | Obstetrics & Gynecology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCEmbaseCASCurrent ContentsPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.26LetPub ·
- Impact factor (publisher)
- 4.3Publisher website ·
- Impact factor (publisher) 2025
- 4.3Publisher website ·
- CiteScore 2026-06
- 6.3LetPub ·
- CiteScore (publisher)
- 6.3Publisher website ·
- CiteScore (publisher) 2025
- 6.3Publisher website ·
- SJR 2026-06
- 1.14LetPub ·
- SNIP 2026-06
- 1.37LetPub ·
- h-index
- 60OpenAlex ·
- i10-index
- 485OpenAlex ·
- 2-year mean citedness
- 4.03OpenAlex ·
- Self-citation rate
- 7%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 81LetPub ·
- Articles per year (publisher) 2025
- 87Publisher website ·
- Downloads per year (publisher) 2025
- 293,822Publisher website ·
Articles by year OpenAlex count · 1,265 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 92 | 92 | 47 |
| 2025 | 93 | 93 | 262 |
| 2024 | 64 | 64 | 695 |
| 2023 | 65 | 65 | 725 |
| 2022 | 57 | 57 | 991 |
| 2021 | 79 | 79 | 1,342 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
91 daysMedian, submission to acceptance · P25–P75 55 days – 127 days
- Acceptance to online
- median 14 days (99 articles)
- Submission to online
- median 106 days
- Sample
- 99 articles with submission and acceptance dates (181 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 20 weeksLetPub ·
- Acceptance rate (publisher)
- 21%Publisher website ·
- Acceptance rate (publisher) 2025
- 21%Publisher website ·
- Submission to first decision
- 6 daysPublisher website ·
- Submission to first decision 2025
- 6 daysPublisher website ·
- Submission to acceptance 2025
- 97 daysPublisher website ·
- Acceptance to publication 2025
- 19 daysPublisher website ·
- Submission to publication (journal-reported)
- about 20 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,850 / GBP 1,250 / EUR 1,650 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 1,850 / EUR 1,650 / GBP 1,250 | — | — | |
| LetPub | EUR 1,650 / GBP 1,250 / USD 1,850 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted10, with length limits
- case reportsOriginal Articles, Research Notes, and Case Reports will be accepted, but not preliminary reports.Length not stated
- commentarye: In general, total of no more than 5. Commentary/Opinion/Perspective Word limit: 1500 words including abstract and references. References: no more thanmain text ≤ 1,500 words · abstract ≤ 100 words · figures and tables ≤ 10
- editorial articlesEditorial articles are usually submitted upon invitation by the Editors.Length not stated
- mini reviewthe time of submission. Word limit for Mini Review Article: In general, 8640 words including abstract and references. References for Mini Revimain text ≤ 8,640 words
- opinionCommentary, Opinion, Perspective are also considered for review.Length not stated
- original articlesOriginal Articles, Research Notes, and Case Reports will be accepted, but not preliminary reports.Length not stated
- perspectiveCommentary, Opinion, Perspective are also considered for review.Length not stated
- research notesOriginal Articles, Research Notes, and Case Reports will be accepted, but not preliminary reports.Length not stated
- reviewReview and Mini review articles are usually submitted upon invitation by the Editors, but the Editorial Board welcomes voluntary contributions.Length not stated
- review articleWhether the paper will be published as Review Article or Mini Review Article will be examined based on the following bases and determined by the editorial offic…main text ≤ 8,640 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Plagiarism, Preprints
- AI use DISCLOSING THE USE OF ARTIFICIAL INTELLIGENCE (AI)
AI use must be described transparently and in detail in the Methods section. Model summary
If you or your co-authors have used Artificial Intelligence Generated Content (AIGC) tools such as ChatGPT and others based on large language models (LLMs) to develop any portion of a manuscript, their use must be described transparently and in detail in the Methods section.Find more details on Wiley’s AI guidelines for researchers and Wiley’s AI policy in full in the Best Practices Guidelines on …
Source ↗Publisher website ·- Authorship AUTHORSHIP
All listed authors should have contributed to the manuscript substantially and have agreed to the final submitted version.
Source ↗Publisher website ·- Conflicts of interest POTENTIAL CONFLICT OF INTEREST
All authors should declare any financial support or relationship that may pose conflict of interest as “Disclosure Statement” between Acknowledgements and References sections.You should disclose any potential conflicts of interests (also referred to as “competing interests”) that might appear to affect your or your co-author’s ability to present work objectively.These might include relevant financ…
Source ↗Publisher website ·- Data availability Data Sharing and Data Accessibility
The journal encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.
Source ↗Publisher website ·- License & copyright COPYRIGHT PERMISSIONS
Permission required for previously published figures, tables, or text passages. Model summary
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Source ↗Publisher website ·- Open access Open Access Agreement (OAA)
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
Source ↗Publisher website ·- Peer review PEER REVIEW AND ACCEPTANCE
Before peer review: Submission of a manuscript implies that the work described has not been published before; that it is not under consideration for publication elsewhere in any language and that its publication has been approved by all co-authors, if any, as well as by the responsible authorities—tacitly or explicitly—at the institute where the work has been carried out.
Source ↗Publisher website ·- Plagiarism
Plagiarism, including self-plagiarism, is prohibited; manuscripts are screened by CrossCheck. Model summary
Journal policy prohibits use of plagiarized text, including self-plagiarism (i.e., using your own text that has previously been published).
Source ↗Publisher website ·- Preprints PREPRINT POLICY
Preprint policy: articles previously available as preprints will be considered for review. Model summary
Reproductive Medicine and Biology will consider for review articles previously available as preprints. Authors are requested to update any pre-publication versions with a link to the final published article. Authors may also post the final published version of the article immediately after publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- WILEY
- Country or region
- JAPAN
- Language
- English
- ISSN
- 1445-5781
- Electronic ISSN
- 1447-0578
- Latest issue on the website
- Volume 25, Issue 1 (December 2026)
- Official links
FAQ
Frequently asked questions about Reproductive Medicine and Biology
What CAS zone is Reproductive Medicine and Biology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Reproductive Medicine and Biology is in Zone 3 of Medicine, and in Zone 3 of the minor category Obstetrics & Gynecology / Reproductive Biology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Reproductive Medicine and Biology?
The latest impact factor listed by LetPub is 4.26; CiteScore 6.3, h-index 60.
How long does peer review take at Reproductive Medicine and Biology?
Based on the dates recorded on 99 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 91 days (interquartile range 55–127 days); authors report an average review time of about 20 weeks; the journal's website gives an acceptance rate of 21% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Reproductive Medicine and Biology based?
Of the 74 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are Japan (59), South Korea (3) and Taiwan, China (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Reproductive Medicine and Biology?
According to LetPub and DOAJ records, Reproductive Medicine and Biology is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, PMC, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Reproductive Medicine and Biology open access, and what is the APC?
Reproductive Medicine and Biology is a fully open-access journal. APC about USD 1,850.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .